Huang YC - Search Results

1

Metformin induces cytotoxicity by down-regulating thymidine phosphorylase and excision repair cross-complementation 1 expression in non-small cell lung cancer cells.

Ko JC, Huang YC, Chen HJ, Tseng SC, Chiu HC, Wo TY, Huang YJ, Weng SH, Chiou RY, Lin YW. Ko JC, et al. Among authors: huang yj, huang yc. Basic Clin Pharmacol Toxicol. 2013 Jul;113(1):56-65. doi: 10.1111/bcpt.12052. Epub 2013 Mar 21. Basic Clin Pharmacol Toxicol. 2013. PMID: 23362830 Free article.

2

Inhibition of p38 MAPK-dependent excision repair cross-complementing 1 expression decreases the DNA repair capacity to sensitize lung cancer cells to etoposide.

Tsai MS, Weng SH, Chen HJ, Chiu YF, Huang YC, Tseng SC, Kuo YH, Lin YW. Tsai MS, et al. Among authors: huang yc. Mol Cancer Ther. 2012 Mar;11(3):561-71. doi: 10.1158/1535-7163.MCT-11-0684. Epub 2011 Nov 3. Mol Cancer Ther. 2012. PMID: 22053010

3

Inhibition of thymidine phosphorylase expression by using an HSP90 inhibitor potentiates the cytotoxic effect of cisplatin in non-small-cell lung cancer cells.

Weng SH, Tseng SC, Huang YC, Chen HJ, Lin YW. Weng SH, et al. Among authors: huang yc. Biochem Pharmacol. 2012 Jul 1;84(1):126-36. doi: 10.1016/j.bcp.2012.03.011. Epub 2012 Mar 27. Biochem Pharmacol. 2012. PMID: 22480737

4

HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells.

Ko JC, Chen HJ, Huang YC, Tseng SC, Weng SH, Wo TY, Huang YJ, Chiu HC, Tsai MS, Chiou RY, Lin YW. Ko JC, et al. Among authors: huang yj, huang yc. Regul Toxicol Pharmacol. 2012 Dec;64(3):415-24. doi: 10.1016/j.yrtph.2012.10.003. Epub 2012 Oct 13. Regul Toxicol Pharmacol. 2012. PMID: 23069143

5

Metformin-mediated downregulation of p38 mitogen-activated protein kinase-dependent excision repair cross-complementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to paclitaxel.

Tseng SC, Huang YC, Chen HJ, Chiu HC, Huang YJ, Wo TY, Weng SH, Lin YW. Tseng SC, et al. Among authors: huang yj, huang yc. Biochem Pharmacol. 2013 Feb 15;85(4):583-94. doi: 10.1016/j.bcp.2012.12.001. Epub 2012 Dec 7. Biochem Pharmacol. 2013. PMID: 23228696

6

Pemetrexed downregulates ERCC1 expression and enhances cytotoxicity effected by resveratrol in human nonsmall cell lung cancer cells.

Chen RS, Ko JC, Chiu HC, Wo TY, Huang YJ, Tseng SC, Chen HJ, Huang YC, Jian YJ, Lee WT, Lin YW. Chen RS, et al. Among authors: huang yj, huang yc. Naunyn Schmiedebergs Arch Pharmacol. 2013 Dec;386(12):1047-59. doi: 10.1007/s00210-013-0905-9. Epub 2013 Aug 3. Naunyn Schmiedebergs Arch Pharmacol. 2013. PMID: 23912706

7

Inhibition of p38 MAPK-dependent MutS homologue-2 (MSH2) expression by metformin enhances gefitinib-induced cytotoxicity in human squamous lung cancer cells.

Ko JC, Chiu HC, Wo TY, Huang YJ, Tseng SC, Huang YC, Chen HJ, Syu JJ, Chen CY, Jian YT, Jian YJ, Lin YW. Ko JC, et al. Among authors: huang yj, huang yc. Lung Cancer. 2013 Dec;82(3):397-406. doi: 10.1016/j.lungcan.2013.09.011. Epub 2013 Sep 25. Lung Cancer. 2013. PMID: 24138903

8

Galangin ameliorates cisplatin-induced nephrotoxicity by attenuating oxidative stress, inflammation and cell death in mice through inhibition of ERK and NF-kappaB signaling.

Huang YC, Tsai MS, Hsieh PC, Shih JH, Wang TS, Wang YC, Lin TH, Wang SH. Huang YC, et al. Toxicol Appl Pharmacol. 2017 Aug 15;329:128-139. doi: 10.1016/j.taap.2017.05.034. Epub 2017 May 27. Toxicol Appl Pharmacol. 2017. PMID: 28558962

9

FGFR1 mediates recombinant thrombomodulin domain-induced angiogenesis.

Kuo CH, Sung MC, Chen PK, Chang BI, Lee FT, Cho CF, Hsieh TT, Huang YC, Li YH, Shi GY, Luo CY, Wu HL. Kuo CH, et al. Among authors: huang yc. Cardiovasc Res. 2015 Jan 1;105(1):107-17. doi: 10.1093/cvr/cvu239. Epub 2014 Nov 10. Cardiovasc Res. 2015. PMID: 25388665

10

Dose-normalization for exposure to mycophenolic acid and the early clinical outcome in patients taking tacrolimus after heart transplantation.

Roan JN, Chou CH, Hsu CH, Wu SY, Huang YC, Yang YJ, Luo CY. Roan JN, et al. Among authors: huang yc. Ann Transplant. 2013 Feb 5;18:43-52. doi: 10.12659/AOT.883812. Ann Transplant. 2013. PMID: 23792500 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,526 results

Search Page